Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory impairment and cognitive dysfunctions. It has been shown that hypoglycemia can adversely affect AD neuropathology. It is well-known that chronic hyperglycemia in type 2 diabetes (T2D) is regarded as a po...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cellular and molecular neurobiology 2024, Vol.44 (1), p.55, Article 55
Hauptverfasser:	Ali, Naif H., Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Hadi, Najah R., Assiri, Abdullah A., Alrouji, Mohammed, Welson, Nermeen N., Alexiou, Athanasios, Papadakis, Marios, Batiha, Gaber El-Saber
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - metabolism Alzheimer Disease - pathology Alzheimer's disease Animals Biomedical and Life Sciences Biomedicine Blood glucose Brain injury Cell Biology Cognitive ability Diabetes mellitus (non-insulin dependent) Glucagon Hippocampal plasticity Hippocampus Humans Hyperglycemia Hypoglycemia Hypoglycemia - complications Hypoglycemia - metabolism Immunological memory Memory Neurobiology Neurodegenerative diseases Neuropathology Neurosciences Phosphorylation Review Paper Risk Factors Synaptic plasticity Synaptogenesis Tau protein Thrombosis β-Amyloid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!